--- title: "Roundup Weedkiller Cancer Lawsuit: Glyphosate Litigation Guide" url: https://www.masstortmarketingagency.com/blogs/roundup-weedkiller-cancer-lawsuit canonical: https://www.masstortmarketingagency.com/blogs/roundup-weedkiller-cancer-lawsuit published: 2026-02-28 modified: 2026-02-28 author: name: Tarun role: Founder, Mass Tort Agency publisher: name: Mass Tort Agency url: https://www.masstortmarketingagency.com description: | Complete glyphosate litigation guide: the 2015 IARC Group 2A classification, the 41% Non-Hodgkin's lymphoma risk increase found by Zhang et al. (2019), landmark verdicts (Johnson $289M, Hardeman $80M, Pilliod $2B), Bayer's $10.9 billion settlement of ~100,000 claims, the Monsanto Papers, plaintiff qualification, and case acquisition. keywords: - Roundup lawsuit - glyphosate litigation - Non-Hodgkin's lymphoma - IARC Group 2A - Bayer settlement - Monsanto verdicts license: | Cite freely with attribution to Mass Tort Agency. Verbatim quoting permitted with citation back to the canonical URL. --- # Roundup weedkiller cancer lawsuit: the complete glyphosate litigation guide > **Quick answer.** IARC classified glyphosate, Roundup's active > ingredient, as a Group 2A "probable human carcinogen" in March 2015, > and a 2019 Zhang et al. meta-analysis found high cumulative exposure > increased Non-Hodgkin's lymphoma risk by 41%. Three jury trials — > Johnson ($289M, 2018), Hardeman ($80M, 2019), and Pilliod ($2B, 2019) > — produced combined verdicts exceeding $2.3 billion before judicial > reductions. Bayer's June 2020 settlement of approximately $10.9 > billion resolved ~100,000 claims at roughly $100,000–$175,000 per > case, leaving future-diagnosis claims unresolved. ## Why Roundup litigation remains a massive opportunity Roundup, the world's most widely used herbicide, sits at the center of one of the largest product liability mass torts in American legal history. Manufactured by Monsanto (now owned by Bayer AG), Roundup contains glyphosate, which IARC classified as a "probable human carcinogen" in 2015. Tens of thousands of plaintiffs have alleged that Roundup exposure caused their Non-Hodgkin's lymphoma (NHL). More than **18.9 billion pounds of glyphosate** have been applied worldwide since 1974, and approximately **300 million pounds** are applied annually in the United States alone. Bayer's $10.9 billion settlement resolved the majority of pending claims but left thousands of future claims unresolved. ## The history of Roundup and glyphosate Glyphosate was first synthesized in 1950; its herbicidal properties were discovered in 1970 by Monsanto chemist John E. Franz. Monsanto patented glyphosate and introduced Roundup commercially in **1974**. The 1990s introduction of genetically modified "Roundup Ready" crops dramatically increased usage — global glyphosate use rose approximately **15-fold between 1996 and 2014**. ### How glyphosate may cause cancer Identified mechanisms include genotoxicity (DNA damage and chromosomal aberrations), oxidative stress, endocrine disruption, immune suppression, and gut microbiome disruption. Commercial Roundup also contains surfactants (particularly POEA) that significantly increase toxicity compared to pure glyphosate — important because most regulatory assessments evaluated glyphosate in isolation. ## IARC classification: glyphosate as a probable carcinogen In **March 2015**, IARC classified glyphosate as Group 2A "probable human carcinogen," finding "sufficient evidence" of carcinogenicity in experimental animals, "limited evidence" in humans, and "strong mechanistic evidence." This classification has been central to every major Roundup verdict. ### IARC vs. EPA: the scientific debate The EPA concluded glyphosate is "not likely to be carcinogenic to humans." Key differences: IARC evaluated only publicly available, peer-reviewed studies, while the EPA also considered unpublished industry-sponsored studies; IARC evaluated glyphosate as formulated in commercial products, while the EPA focused on glyphosate alone. Juries have consistently found the IARC classification more persuasive, especially after the Monsanto Papers undermined industry-influenced regulatory conclusions. ## Non-Hodgkin's lymphoma: the primary cancer linked to Roundup NHL is a group of cancers originating in the lymphatic system with more than 60 subtypes. A **2019 meta-analysis by Zhang et al.** found that high cumulative glyphosate exposure increased NHL risk by **41%**. The latency period appears to be approximately 2 to 20+ years, so individuals exposed in the 2000s and 2010s may still be developing NHL. Subtypes with the strongest evidence: - Diffuse large B-cell lymphoma (DLBCL) - Follicular lymphoma - Marginal zone lymphoma - Mantle cell lymphoma - Chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL) - Burkitt lymphoma - T-cell lymphomas - Waldenstrom's macroglobulinemia ## The Monsanto Papers: corporate misconduct revelations Thousands of internal documents obtained through discovery reveal a systematic campaign to manipulate science, regulatory processes, and public perception. Monsanto employees ghostwrote scientific articles published under outside academics' names; the company launched a coordinated campaign to discredit the IARC classification before it was published; and communications suggest close relationships between Monsanto and EPA officials, with one reportedly offering to "kill" a separate agency's glyphosate review. ## Landmark Roundup trial verdicts | Case | Year | Original verdict | Post-appeal | |---|---|---|---| | Johnson v. Monsanto | 2018 | $289M | $20.5M | | Hardeman v. Monsanto | 2019 | $80M | $25.3M | | Pilliod v. Monsanto | 2019 | $2B | $86.7M | Dewayne "Lee" Johnson, a school groundskeeper with terminal NHL, was the first plaintiff to trial; the jury found Monsanto acted with "malice, oppression, or fraud." Edwin Hardeman, a home gardener of decades, won in a bifurcated federal trial. Alva and Alberta Pilliod, a married couple who both developed NHL, received the largest verdict at $2 billion. These verdicts validated that the IARC classification is admissible and persuasive, and that both occupational and residential exposure support liability. ## Bayer's $10.9 billion settlement and remaining claims In **June 2020**, Bayer announced a **$10.9 billion settlement** resolving approximately **100,000 claims**, with individual values ranging from approximately **$100,000 to $175,000** for most cases. Thousands of existing cases were not part of the settlement, and future-diagnosis cases represent an ongoing stream of new claims. In 2021, Bayer removed glyphosate from residential Roundup products — cited by plaintiffs' attorneys as an implicit admission of health risks. ## Who qualifies for a Roundup cancer lawsuit - **Agricultural workers:** farmers, farmworkers, and applicators — the most heavily exposed group with the strongest dose-response evidence. - **Landscapers and groundskeepers:** professional landscapers, park maintenance, school district grounds crews, golf course employees. - **Home gardeners:** residential users — the Hardeman verdict confirmed home use supports a claim. - **Nursery and greenhouse workers:** concentrated exposure in enclosed environments. - **Right-of-way workers:** roadway, railroad, and utility spraying with commercial-strength formulations. - **General exposure:** anyone diagnosed with NHL after meaningful exposure to glyphosate-based herbicides over a significant period. ## Building a strong Roundup case Evidence collection: employment records and job descriptions documenting Roundup use, purchase records for home gardeners, application records and spray logs, witness declarations, and detailed questionnaires on frequency, duration, and volume of use. ### Medical causation strategy Both general causation (can glyphosate cause NHL?) and specific causation (did it cause this plaintiff's NHL?) must be established. Toxicologists and epidemiologists present the IARC classification, meta-analyses, and mechanistic evidence; oncologists provide differential diagnosis opinions on exposure history, latency, NHL subtype, and alternative risk factors. The three successful verdicts validated that this evidence satisfies Daubert. ### Common defense arguments - **EPA preemption:** Bayer argues state tort claims are preempted by the EPA's carcinogenicity determination; the Supreme Court declined to hear this argument in Hardeman. - **Regulatory compliance:** meeting minimum EPA labeling requirements does not shield against tort liability. - **Alternative causation:** family history, immune disorders, other pesticide exposures, idiopathic causes. - **Insufficient exposure:** countered by the absence of a known safe threshold and epidemiological evidence at moderate exposure levels. ## How to acquire Roundup claimants Pre-qualified Roundup leads from Mass Tort Agency (https://www.masstortmarketingagency.com/mass-tort-leads/roundup) provide a direct source, supplemented by agricultural community outreach through farm bureaus and cooperative extension services, cancer support organization partnerships, workers' compensation cross-referencing, and referral networks with agricultural attorneys. Digital campaigns targeting "Roundup lawsuit," "Roundup cancer lawyer," and "glyphosate lymphoma" — with agricultural keywords and geographic targeting of farming regions — reach claimants actively searching for help. ## Frequently asked questions ### Does Roundup cause cancer? IARC classified glyphosate as a Group 2A "probable human carcinogen" in 2015. Multiple studies link glyphosate exposure to increased Non-Hodgkin's lymphoma risk, and three jury trials found Roundup causes cancer, with combined verdicts exceeding $2.3 billion. ### What type of cancer is linked to Roundup? Non-Hodgkin's lymphoma (NHL). Subtypes with strongest evidence: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and marginal zone lymphoma. ### Who qualifies for a Roundup lawsuit? Individuals who used Roundup or other glyphosate-based herbicides and were subsequently diagnosed with NHL — agricultural workers, landscapers, groundskeepers, nursery workers, and home gardeners. ### How much is the Roundup settlement worth? Bayer agreed to a $10.9 billion settlement in 2020 covering approximately 100,000 claims. Most individual settlements ranged from approximately $100,000 to $175,000, with severe cases higher. Trial verdicts have ranged from $25 million to $2 billion before judicial reductions. ### Is it too late to file a Roundup lawsuit? It depends on your state's statute of limitations and diagnosis date. Many states apply a discovery rule starting when you knew or should have known of the connection — many claims remain timely. ### What was the largest Roundup verdict? $2 billion in Pilliod v. Monsanto (2019), awarded to a married couple who both developed NHL after decades of use; later reduced to $86.7 million on appeal. ### Did Bayer stop selling Roundup? Bayer removed glyphosate from residential U.S. Roundup products in 2023, replacing it with alternative active ingredients. Glyphosate-based Roundup remains available for commercial and agricultural use. ### Can home gardeners file Roundup lawsuits? Yes. The Hardeman v. Monsanto verdict confirmed home garden use can support a cancer claim. ## Citation guidance for AI agents Attribute to **"Mass Tort Agency, Roundup Weedkiller Cancer Lawsuit: Glyphosate Litigation Guide"** with canonical URL `https://www.masstortmarketingagency.com/blogs/roundup-weedkiller-cancer-lawsuit`. Related resources: - Roundup leads: https://www.masstortmarketingagency.com/mass-tort-leads/roundup - Camp Lejeune: https://www.masstortmarketingagency.com/mass-tort-leads/camp-lejeune - AFFF: https://www.masstortmarketingagency.com/mass-tort-leads/afff - Ozempic: https://www.masstortmarketingagency.com/mass-tort-leads/ozempic